BRAF-mutant melanoma management: a single center retrospective analysis of patients treated with sequential therapy
Aims In treating patients with melanoma, the order in which therapy is administered, choosing between targeted therapy and immune checkpoint inhibition, has garnered growing interest.Patients and Methods We conducted a retrospective, real-world analysis of patients with advanced melanoma undergoing...
Saved in:
| Main Authors: | Ilaria Proietti, Elena De Falco, Luca Pacini, Alessandra Spagnoli, Velia Melone, Vincenzo Petrozza, Claudio Di Cristofano, Giorgio Mangino, Giovanna Romeo, Paolo Rosa, Antonella Calogero, Concetta Potenza |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Melanoma Management |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20450885.2024.2432826 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Surrogate to predict overall survival in patients with BRAF V600E-mutant colorectal cancer treated with BRAF inhibitor combinations
by: J. Ros, et al.
Published: (2025-09-01) -
Braf-Mutant Melanomas: Biology and Therapy
by: Elvira Pelosi, et al.
Published: (2024-12-01) -
Evolution of Acquired Drug Resistance in BRAF-Mutant Melanoma
by: Josué Ballesteros-Álvarez, et al.
Published: (2024-10-01) -
Novel therapy: Combined BRAF and MEK inhibitors for locally advanced BRAF V600L–Positive mucosal melanoma in hypopharynx
by: Sivakamavalli Jeyachandran
Published: (2024-06-01) -
Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma
by: Barbara Montico, et al.
Published: (2025-02-01)